Compare · CGIX vs ELV
CGIX vs ELV
Side-by-side comparison of Cancer Genetics, Inc. (CGIX) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGIX and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV carries a market cap of $89.39B.
- ELV has hit the wire 7 times in the past 4 weeks while CGIX has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 0 for CGIX).
- Company
- Cancer Genetics, Inc.
- Elevance Health Inc.
- Price
- -
- -
- Market cap
- -
- $89.39B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- n/a
- News (4w)
- 0
- 7
- Recent ratings
- 0
- 23
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest CGIX
- SEC Form 4: John R Fletcher was granted 8,676 units of Common Stock
- SEC Form 4 filed by Marcus Boehm
- SEC Form 4 filed by Joanna Horobin
- SEC Form 4 filed by Howard Mcleod
- SEC Form 4 filed by Yung-Ping Yeh
- SEC Form 4 filed by R. Paul Hansen
- SEC Form 4 filed by E. Geoffrey Harris
- SEC Form 4 filed by Ralf Brandt
- SEC Form 4 filed by D.C. Andrew Lafrence
- SEC Form 4 filed by A John Roberts
Latest ELV
- SEC Form S-3ASR filed by Elevance Health Inc.
- EVP & CFO Kaye Mark sold $4,658,357 worth of shares (10,584 units at $440.13) (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Names Jeff Park President of Carelon
- SEC Form 8-K filed by Elevance Health Inc.
- Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
- The Future of Healthcare: AI-Powered, Coordinated and Proactive Care
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support